The effects of surgery-induced immunosuppression and angiogenesis on tumour growth

Veterinary Journal

Volumn 205, Issue 2, 2015, Pages 175-179

  Kadosawa, Tsuyoshi ^a   Watabe, Ai ^a  

^a RAKUNO GAKUEN UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Dormancy; Immunosuppression; Micrometastases; Oncology; Surgical stress

Indexed keywords

ANGIOSTATIN; CYCLOPHOSPHAMIDE; ENDOSTATIN; ETODOLAC; MONOCLONAL ANTIBODY; PACLITAXEL; PROPRANOLOL; TOCERANIB; VASCULOTROPIN ANTIBODY;

ANGIOGENESIS; APOPTOSIS; BREAST CANCER; CANCER IMMUNOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CYSTECTOMY; CYTOTOXIC T LYMPHOCYTE; GROWTH INHIBITION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; IMMUNOSURVEILLANCE; NATURAL KILLER T CELL; NONHUMAN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURGICAL STRESS; SURVIVAL RATE; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; TUMOR GROWTH; TUMOR IMMUNITY; ANIMAL; IMMUNOSUPPRESSIVE TREATMENT; NEOPLASMS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGICAL STRESS; VETERINARY;

ANIMALS; IMMUNOSUPPRESSION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; STRESS, PHYSIOLOGICAL;

EID: 84946188821     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2015.04.009     Document Type: Review

References (67)

1. Atzil S., Arad M., Glasner A., Abiri N., Avraham R., Greenfeld K., Rosenne E., Beilin B., Ben-Eliyahu S. Blood transfusion promotes cancer progression: A critical role for aged erythrocytes. Anesthesiology 2008, 109:989-997.
2. Bartal I., Melamed R., Greenfeld K., Atzil S., Glasner A., Domankevich V., Naor R., Beilin B., Yardeni I.Z., Ben-Eliyahu S. Immune perturbations in patients along the perioperative period: Alterations in cell surface markers and leukocyte subtypes before and after surgery. Brain, Behavior, and Immunity 2010, 24:376-386.
3. Benish M., Bartal I., Goldfarb Y., Levi B., Avraham R., Raz A., Ben-Eliyahu S. Perioperative use of betablockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Annals of Surgical Oncology 2008, 15:2042-2052.
4. Brivio F., Lissoni P., Alderi G., Barni S., Lavorato F., Fumagalli L. Preoperative interleukin-2 subcutaneous immunotherapy may prolong the survival time in advanced colorectal cancer patients. Oncology 1996, 53:263-268.
5. Burnet F.M. Immunological aspects of malignant disease. Lancet 1967, 1:1171-1174.
6. Burton J.H., Mitchell L., Thamm D.H., Dow S.W., Biller B.J. Low-dose cyclophosphamide selectively decreases regulatory T cells and inhibits angiogenesis in dogs with soft tissue sarcoma. Journal of Veterinary Internal Medicine 2011, 25:920-926.
7. Condeelis J., Pollard J.W. Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006, 124:263-266.
8. Cornell K.K., Bostwick D.G., Cooley D.M., Hall G., Harvey H.J., Hendrick M.J., Pauli B.U., Render J.A., Stoica G., Sweet D.C., et al. Clinical and pathological aspects of spontaneous canine prostate carcinoma: A retrospective analysis of 76 cases. The Prostate 2000, 45:173-183.
9. Damber J.E., Vallbo C., Albertsson P., Lennernäs B., Norrby K. The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondin. Cancer Chemotherapy and Pharmacology 2006, 58:354-360.
10. Decaens T., Roudot-Thoraval F., Bresson-Hadni S., Meyer C., Gugenheim J., Durand F., Bernard P.H., Boillot O., Compagnon P., Calmus Y., et al. Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: A multicenter study of 412 patients. World Journal of Gastroenterology 2006, 12:7319-7325.
11. Demicheli R., Valagussa P., Bonadonna G. Does surgery modify growth kinetics of breast cancer micrometastases?. British Journal of Cancer 2001, 85:490-492.
12. Detry O., Honore P., Meurisse M., Jacquet N. Cancer in transplant recipients. Transplantation Proceedings 2000, 32:127.
13. Ehrlich P., Apolant H. Beobechtungen über maligne Mäusetumoren. Berlin Klinische Wochenschrift 1905, 42:871-874.
14. Fisher B., Fisher E.R. Experimental evidence in support of the dormant tumour cell. Science 1959, 130:918-919.
15. Folkman J. Tumor angiogenesis. Advances in Cancer Research 1985, 43:175-203.
16. Folkman J. Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action. Experimental Cell Research 2006, 312:594-607.
17. Gershon R.K., Carter R.L., Kondo K. Immunologic defenses against metastases: Impairment by excision of an allotransplanted lymphoma. Science 1968, 159:646-648.
18. Glasner A., Avraham R., Rosenne E., Benish M., Zmora O., Shemer S., Meiboom H., Ben-Eliyahu S. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. The Journal of Immunology 2010, 184:2449-2457.
19. Goldfarb Y., Benish M., Rosenne E., Melamed R., Levi B., Glasner A., Ben-Eliyahu S. CpG-C oligodeoxynucleotides limit the deleterious effects of beta-adrenoceptor stimulation on NK cytotoxicity and metastatic dissemination. Journal of Immunotherapy 2009, 32:280-291.
20. Greenfeld K., Avraham R., Benish M., Goldfarb Y., Rosenne E., Shapira Y., Rudich T., Ben-Eliyahu S. Immune suppression while awaiting surgery and following it: Dissociations between plasma cytokine levels, their induced production, and NK cell cytotoxicity. Brain, Behavior, and Immunity 2007, 21:503-513.
21. Hadfield G. The dormant cancer cell. British Medical Journal 1954, 2:607-610.
22. Hofer S.O., Molema G., Hermens R.A., Wanebo H.J., Reichner J.S., Hoekstra H.J. The effect of surgical wounding on tumour development. European Journal of Surgical Oncology 1999, 25:231-243.
23. Holmgren L., O'Reilly M., Folkman J. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Medicine 1995, 1:149-153.
24. Hormbrey E., Han C., Roberts A., McGrouther D.A., Harris A.H. The relationship of human wound vascular endothelial growth factor (VEGF) after breast cancer surgery to circulating VEGF and angiogenesis. Clinical Cancer Research 2003, 9:4332-4339.
25. Ikeda M., Furukawa H., Imamura H., Shimizu J., Ishida H., Masutani S., Tatsuta M., Kawasaki T., Satomi T. Surgery for gastric cancer increases plasma levels of vascular endothelial growth factor and von Willebrand factor. Gastric Cancer 2002, 5:137-141.
26. Inbar S., Neeman E., Avraham R., Benish M., Rosenne E., Ben-Eliyahu S. Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity. PLoS ONE 2011, 6:e19246.
27. Iversen P., Madsen P.O., Corle D.K. Radical prostatectomy versus expectant treatment for early carcinoma of the prostate: Twenty-three year follow-up of a prospective randomized study. Scandinavian Journal of Urology and Nephrology 1995, 172:65-72.
28. Javidnia H., Hanna M., Li Y., Scheer A., Filion L., Eapen L., Carrier M., Auer R., Corsten M., Allan D.S. Vascular progenitor clusters from peripheral blood in cancer patients following oncologic surgery. Journal of Surgical Oncology 2014, 109:151-157.
29. Kadosawa T., Watabe A., Yamashita M., Tomonaga M., Endo Y., Hirayama K., Taniyama H. Total cystectomy and uretero-urethral/preputial/vaginal anastomosis in 23 dogs with transitional cell carcinoma of bladder 2012, 30. In: Proceedings of the 2nd World Veterinary Cancer Congress, Paris, France.
30. Kerbel R.S. Clinical trials of antiangiogenic drugs: Opportunities, problems, and assessment of initial results. Journal of Clinical Oncology 2001, 19:45s-51s.
31. Lacy A.M., Garcia-Valdecasas J.C., Delgado S., Castells A., Taurá P., Piqué J.M., Visa J. Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: A randomized trial. Lancet 2002, 359:2224-2229.
32. Lawler P.R., Lawler J. Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2. Cold Spring Harbor Perspectives in Medicine 2012, 2:a006627.
33. Lee Y.T. Effect of anesthesia and surgery on immunity. Journal of Surgical Oncology 1977, 9:425-430.
34. Li T.S., Kaneda Y., Ueda K., Hamano K., Zempo N., Esato K. The influence of tumor resection on angiostatin levels and tumour growth - An experimental study on tumour bearing mice. European Journal of Cancer 2001, 37:2283-2288.
35. London C., Mathie T., Stingle N., Clifford C., Haney S., Klein M.K., Beaver L., Vickery K., Vail D.M., Hershey B., et al. Preliminary evidence for biologic activity of toceranib phosphate (palladia) in solid tumors. Veterinary and Comparative Oncology 2012, 10:194-205.
36. Ma L., del Soldato P., Wallace J.L. Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: Shifting the angiogenic balance. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:13243-13247.
37. MacEwen E.G., Hayes A.A., Harvey H.J., Patnaik A.K., Mooney S., Passe S. Prognostic factors for feline mammary tumors. Journal of American Veterinary Medical Association 1984, 185:201-204.
38. Maniwa Y., Okada M., Ishii N., Kiyooka K. Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer. Chest 1998, 114:1668-1675.
39. Marie P., Clunet J. Fréquences des métastases viscérales chez les souris cancéreuses après ablation chirurgicale de leur tumeur. Bulletin de l'Assoc Française Pour L'Etude du Cancer 1910, 3:19-23.
40. McCoy J.L., Rucker R., Petros J.A. Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status. Breast Cancer Research and Treatment 2000, 60:227-234.
41. Medleau L., Crowe D.T., Dawe D.L. Effect of surgery on the in vitro response of canine peripheral blood lymphocytes to phytohemagglutinin. American Journal of Veterinary Research 1983, 44:859-860.
42. Melamed R., Bar-Yosef S., Shakhar G., Shakhar K., Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: Mediating mechanisms and prophylactic measures. Anesthesia and Analgesia 2003, 97:1331-1339.
43. Mitchell L., Thamm D.H., Biller B.J. Clinical and immunomodulatory effects of toceranib combined with low-dose cyclophosphamide in dogs with cancer. Veterinary Internal Medicine 2012, 26:355-362.
44. Miyata Y., Sakai H. Thrombospondin-1 in urological cancer: Pathological role, clinical significance, and therapeutic prospects. International Journal of Molecular Sciences 2013, 14:12249-12272.
45. Momosaki K., Ishibashi N., Yoshida S., Muraoka T., Tanaka K., Iwakuma N., Oka Y., Kaibara A., Akagi Y., Shirouzu K. Effect of preoperative administration of methylprednisolone and ulinastatin on tumor cell metastasis after surgical stress. The Kurume Medical Journal 2014, 60:79-88.
46. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Cao Y., Sage E.H., Folkman J. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994, 79:315-328.
47. Penn I. The effect of immunosuppression on pre-existing cancers. Transplantation 1993, 55:742-747.
48. Pollock R.E., Roth J.A. Cancer-induced immunosuppression: Implications for therapy?. Seminars in Surgical Oncology 1989, 5:414-419.
49. Postow M., Callahan M.K., Wolchok J.D. Beyond cancer vaccines: A reason for future optimism with immunomodulatory therapy. Journal of Cancer 2011, 17:372-378.
50. Rabelink T.J., de Boer H.C., de Koning E.J., van Zonneveld A.J. Endothelial progenitor cells: More than an inflammatory response?. Arteriosclerosis, Thrombosis, and Vascular Biology 2004, 24:834-838.
51. Roche-Nagle G., Connolly E.M., Eng M., Bouchier-Hayes D.J., Harmey J.H. Antimetastatic activity of a cyclooxygenase-2 inhibitor. British Journal of Cancer 2004, 91:359-365.
52. Rosenberger P.H., Ickovics J.R., Epel E., Nadler E., Jokl P., Fulkerson J.P., Tillie J.M., Dhabhar F.S. Surgical stress-induced immune cell redistribution profiles predict short-term and long-term postsurgical recovery. Journal of Bone and Joint Surgery American volume 2009, 91:2783-2794.
53. Saito Y., Shimada M., Utsunomiya T., Morine Y., Imura S., Ikemoto T., Mori H., Hanaoka J., Iwahashi S., Yamada S., et al. Regulatory T cells in the blood: A new marker of surgical stress. Surgery Today 2013, 43:608-612.
54. Schadler K.L., Crosby E.J., Zhou A.Y., Bhang D.H., Braunstein L., Baek K.H., Crawford D., Crawford A., Angelosanto J., Wherry E.J., et al. Immunosurveillance by antiangiogenesis: Tumor growth arrest by T cell-derived thrombospondin-1. Cancer Research 2014, 74:2171-2181.
55. Shakhar G., Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: Could they reduce recurrence rates in oncological patients?. Annals of Surgical Oncology 2003, 10:972-992.
56. Shavit Y., Ben-Eliyahu S., Zeidel A., Beilin B. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation 2004, 11:255-260.
57. Sinicrope F.A., Gill S. Role of cyclooxygenase-2 in colorectal cancer. Cancer and Metastasis Reviews 2004, 23:63-75.
58. Sun R., Wu J., Chen Y., Lu M., Zhang S., Lu D., Li Y. Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer. Molecular Cancer 2014, 13:225-234.
59. Tagliabue E., Agresti R., Carcangiu M.L., Ghirelli C., Morelli D., Campiglio M., Martel M., Giovanazzi R., Greco M., Balsari A., et al. Role of HER2 in wound-induced breast carcinoma proliferation. Lancet 2003, 362:527-533.
60. Tai L.H., Zhang J., Auer R.C. Preventing surgery-induced NK cell dysfunction and cancer metastases with influenza vaccination. Oncoimmunology 2013, 2:e26618.
61. Uchida A., Kariya Y., Okamoto N., Sugie K., Fujimoto T., Yagita M. Prediction of postoperative clinical course by autologous tumor-killing activity in lung cancer patients. Journal of the National Cancer Institute 1990, 82:1697-1701.
62. van der Bilt J.D., Borel Rinkes I.H. Surgery and angiogenesis. Biochimica et Biophysica Acta 2004, 1654:95-104.
63. Watabe A., Uesawa H., Kimura T., Fu D.-R., Hagiwara K., Endo Y., Kadosawa T., Hagiwara Y. The effect of surgical stress on regulatory T cells in dogs with cancer 2012, 46. In: Proceedings of the 2nd World Veterinary Cancer Congress, Paris, France.
64. Wei D., Wang L., He Y., Xiong H.Q., Abbruzzese J.L., Xie K. Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity. Cancer Research 2004, 64:2030-2038.
65. Wu F.P.K., Hoeckman K., Meijer S., Cuesta M.A. VEGF and endostatin levels in wound fluids and plasma after breast surgery. Angiogenesis 2003, 6:255-257.
66. Yamaguchi K., Takagi Y., Aoki S., Futamura M., Saji S. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Annals of Surgery 2000, 232:58-65.
67. Yuhas J.M., Pazmino N.H. Inhibition of subcutaneously growing line 1 carcinomas due to metastatic spread. Cancer Research 1974, 34:2005-2010.